Á¦14ȸ °³½ÅÀÇÇÐ Çмú´ëȸ ÀÏÁ¤
½Ã°£: 2010. 12. 3(±Ý)
Àå¼Ò: ÀÇ´ë ÇÕµ¿°ÀǽÇ(±¸¿¬ ¹ßÇ¥), ¸ÖƼ¹Ìµð¾î½Ç(ÀüÀÚÆ÷½ºÅÍ Àü½Ã)
1:00 - 1:15µî·Ï
1:15 - 1:30°³È¸»ç---------------- ÀÇÇבּ¸¼ÒÀå
Ãà»ç ------------------ Àǰú´ëÇÐÀå/ÀÇÇÐÀü¹®´ëÇпøÀå
Çмú»ó ½Ã»ó½Ä
Çмú»ó ¼ö»ó¿¬Á¦
1:30 - 1:50¼ö»ó¿¬Á¦ (ÀÓ»ó) ÁÂÀå : ½Å½Ã¿Á (ÀÓ»óÀÇÇבּ¸¼ÒÀå)
1:50 - 2:10 ¼ö»ó¿¬Á¦ (±âÃÊ) ÁÂÀå : ±èÀÀ±¹ (¿¬±¸ ºÎÇÐÀå)
2:10 - 2:30 ÈÞ½Ä ¹× Æ÷½ºÅÍ ¹ßÇ¥
ÁöÁ¤¿¬Á¦ : À¯ÀüüÀÇ ¿¬±¸ ¹× Ȱ¿ë
°¢ 20ºÐ ¹ßÇ¥, 10ºÐ Åä·Ð
ÃæºÏ´ëÇб³ MRC ¹× ERC ÁÂÀå : ÀÌ»ó¼ö (ÃæºÏÀÇ´ë ½Å°æ°úÇб³½Ç)
2:30 - 3:00bFGF induces the expression of Bcl2-A1 and Bcl-xL genes to inhibit the apoptosis of ATDC5 chondroprogenitor cells
- ÃÖÁß±¹ (ÃæºÏ´ëÇб³ MRC)Åä·Ð: È«Á¾¸é, ¼Á¦ÈÆ, ÀÌ¿ëÈñ
3:00 - 3:30 Regulation of cell migration by myosin II and Rho GEFs
- ½ÅÀº¿µ (ÃæºÏ´ëÇб³ MRC)Åä·Ð: ±èÇü±Ô, À̱⸸, ±èÂùÇü
3:30 - 4:00 Gene expression profiling to identify genetic signature of bladder cancer
- ±è¿øÀç (ÃæºÏ´ëÇб³ ERC, ±è¼±±Ô)Åä·Ð: ÀÌ»óö, ÀÌ¿ÁÁØ, ÃÖ¿µ±â
4:00 - 4:30 ÷´ÜÀǷẹÇÕ´ÜÁö Ȱ¼ºÈ¸¦ À§ÇÑ ÃæºÏ´ëÇб³ÀÇ·á±â±âÀÓ»ó½ÃÇè¼¾ÅÍ »ç¾÷
- Â÷ÀºÁ¾ (ÃæºÏ´ëÇб³ ERC)Åä·Ð: ±è¼ºÁø, ÀÌÀº¿µ, ±èÇå½Ä
4:30 - 4:50ÈÞ½Ä ¹× Æ÷½ºÅÍ ¹ßÇ¥
±¹¸³º¸°Ç¿¬±¸¿ø: ¸ÂÃãÄ¡·á¸¦ À§ÇÑ À¯Àüü ¿¬±¸ ÁÂÀå : Á¶¸íÂù (±¹¸³º¸°Ç¿¬±¸¿øÀå)
4:50 - 5:20Çѱ¹ÀÎ À¯Àüü ¿ªÇÐ(KoGES)
- ±è¼º¼ö (±¹¸³º¸°Ç¿¬±¸¿ø À¯Àüü ¼¾ÅÍ À¯Àüü¿ªÇаúÀå)
Åä·Ð: ÃÖÁß±¹, ±è¹Ì°æ, ±èÁöÀ±
5:20 - 5:50 À¯Àüü ÇüÁú¿¬±¸¶õ?
- ÀÌÁ¾¿µ (±¹¸³º¸°Ç¿¬±¸¿ø À¯Àüü ¼¾ÅÍ ÇüÁú¿¬±¸°úÀå)
Åä·Ð: ¹ÚÁø¿ì, ½ÅÀº¿µ, ±è½Â·Ä
5:50 - 6:20Bioinformatics and medical informatics
- ¹Ú±âÁ¤ (±¹¸³º¸°Ç¿¬±¸¿ø À¯Àüü ¼¾ÅÍ ¹ÙÀÌ¿À°úÇÐÁ¤º¸°úÀå)
Åä·Ð: °±æ¿ø, °Á¾¿ø, Â÷»óÈÆ
6:20Æóȸ
|